{"entity":{"type":"insider","cik":"0001605767","url":"/insider/0001605767","json_url":"/insider/0001605767.json","name":"Bazemore Todd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":16,"first":"2015-08-06","last":"2025-10-24","span_basis":"filed_date"},"name_variants":[{"name":"Bazemore Todd","source":"filing","n_filings":16,"first_seen":"2015-08-06","last_seen":"2025-10-24"}],"transactions":[{"id":4403492,"accession":"0001605767-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001605767-25-000004","line_url":"/filing/0001605767-25-000004#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47768.0,"shares_display":"47,768","price_per_share":0.83,"price_display":"0.83","price_state":"stated","total_value":39647.44,"total_display":"39,647.44","total_whole":"39,647","shares_owned_after":35932.0,"shares_owned_after_display":"35,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-22","filed_date":"2025-10-24","scope":"insider"},{"id":4558601,"accession":"0001415889-25-018319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-018319","line_url":"/filing/0001415889-25-018319#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4058.0,"shares_display":"4,058","price_per_share":4.01,"price_display":"4.01","price_state":"stated","total_value":16272.58,"total_display":"16,272.58","total_whole":"16,273","shares_owned_after":83699.0,"shares_owned_after_display":"83,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-26","scope":"insider"},{"id":4245670,"accession":"0001415889-25-015679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015679","line_url":"/filing/0001415889-25-015679#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3390.0,"shares_display":"3,390","price_per_share":3.74,"price_display":"3.74","price_state":"stated","total_value":12678.6,"total_display":"12,678.60","total_whole":"12,679","shares_owned_after":87757.0,"shares_owned_after_display":"87,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-04","scope":"insider"},{"id":5192512,"accession":"0001415889-25-001062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-001062","line_url":"/filing/0001415889-25-001062#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1993.0,"shares_display":"1,993","price_per_share":7.63,"price_display":"7.63","price_state":"stated","total_value":15206.59,"total_display":"15,206.59","total_whole":"15,207","shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":2661492,"accession":"0001415889-24-018377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-018377","line_url":"/filing/0001415889-24-018377#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4653.0,"shares_display":"4,653","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":22101.75,"total_display":"22,101.75","total_whole":"22,102","shares_owned_after":83040.0,"shares_owned_after_display":"83,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-26","filed_date":"2024-06-27","scope":"insider"},{"id":2999924,"accession":"0001415889-24-015226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-015226","line_url":"/filing/0001415889-24-015226#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2093.0,"shares_display":"2,093","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":12746.37,"total_display":"12,746.37","total_whole":"12,746","shares_owned_after":87693.0,"shares_owned_after_display":"87,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-03","scope":"insider"},{"id":2483441,"accession":"0001415889-24-000766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-000766","line_url":"/filing/0001415889-24-000766#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":6.74,"price_display":"6.74","price_state":"stated","total_value":9469.7,"total_display":"9,469.70","total_whole":"9,470","shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-05","scope":"insider"},{"id":7907189,"accession":"0001415889-23-000637","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-000637","line_url":"/filing/0001415889-23-000637#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62.0,"shares_display":"62","price_per_share":28.54,"price_display":"28.54","price_state":"stated","total_value":1769.48,"total_display":"1,769.48","total_whole":"1,769","shares_owned_after":14835.0,"shares_owned_after_display":"14,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider"},{"id":6818753,"accession":"0001415889-22-010881","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-010881","line_url":"/filing/0001415889-22-010881#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":214.0,"shares_display":"214","price_per_share":6.51,"price_display":"6.51","price_state":"stated","total_value":1393.14,"total_display":"1,393.14","total_whole":"1,393","shares_owned_after":2097.0,"shares_owned_after_display":"2,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-28","scope":"insider"},{"id":6757686,"accession":"0001415889-22-007060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-007060","line_url":"/filing/0001415889-22-007060#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3092.0,"shares_display":"3,092","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":1144.04,"total_display":"1,144.04","total_whole":"1,144","shares_owned_after":115499.0,"shares_owned_after_display":"115,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"},{"id":6679750,"accession":"0001415889-22-000403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-000403","line_url":"/filing/0001415889-22-000403#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3454.0,"shares_display":"3,454","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":4490.2,"total_display":"4,490.20","total_whole":"4,490","shares_owned_after":118591.0,"shares_owned_after_display":"118,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider"},{"id":4354148,"accession":"0001415889-21-005011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-005011","line_url":"/filing/0001415889-21-005011#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12544.0,"shares_display":"12,544","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":22579.2,"total_display":"22,579.20","total_whole":"22,579","shares_owned_after":122045.0,"shares_owned_after_display":"122,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-28","scope":"insider"},{"id":4300232,"accession":"0001415889-21-003257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-003257","line_url":"/filing/0001415889-21-003257#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2911.0,"shares_display":"2,911","price_per_share":5.77,"price_display":"5.77","price_state":"stated","total_value":16796.47,"total_display":"16,796.47","total_whole":"16,796","shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-29","scope":"insider"},{"id":3337201,"accession":"0001179110-20-010711","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-010711","line_url":"/filing/0001179110-20-010711#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40.0,"shares_display":"40","price_per_share":7.6,"price_display":"7.60","price_state":"stated","total_value":304.0,"total_display":"304.00","total_whole":"304","shares_owned_after":42.0,"shares_owned_after_display":"42","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-22","filed_date":"2020-10-28","scope":"insider"},{"id":3337197,"accession":"0001179110-20-010711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-010711","line_url":"/filing/0001179110-20-010711#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2.0,"shares_display":"2","price_per_share":13.39,"price_display":"13.39","price_state":"stated","total_value":26.78,"total_display":"26.78","total_whole":"27","shares_owned_after":2.0,"shares_owned_after_display":"2","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-05","filed_date":"2020-10-28","scope":"insider"},{"id":2755890,"accession":"0001179110-20-003841","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-003841","line_url":"/filing/0001179110-20-003841#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":57500.0,"total_display":"57,500.00","total_whole":"57,500","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-17","scope":"insider"},{"id":8482607,"accession":"0000908662-15-000280","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000908662-15-000280","line_url":"/filing/0000908662-15-000280#line-4","is_derivative":false,"issuer_cik":"0000907562","issuer_name":"DYAX CORP","issuer_ticker":"DYAX","issuer_name_source":null,"issuer_url":"/issuer/0000907562","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":23.5305,"price_display":"23.53","price_state":"stated","total_value":235305.0,"total_display":"235,305.00","total_whole":"235,305","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-05","filed_date":"2015-08-06","scope":"insider"},{"id":8482599,"accession":"0000908662-15-000280","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000908662-15-000280","line_url":"/filing/0000908662-15-000280#line-2","is_derivative":false,"issuer_cik":"0000907562","issuer_name":"DYAX CORP","issuer_ticker":"DYAX","issuer_name_source":null,"issuer_url":"/issuer/0000907562","owner_cik":"0001605767","owner_name":"Bazemore Todd","owner_display_name":"Bazemore Todd","owner_url":"/insider/0001605767","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33000.0,"shares_display":"33,000","price_per_share":23.646,"price_display":"23.65","price_state":"stated","total_value":780318.0,"total_display":"780,318.00","total_whole":"780,318","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-04","filed_date":"2015-08-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001479419","name":"KALA BIO, Inc.","url":"/issuer/0001479419","role":"Director, Officer","n_filings":15,"first_seen":"2020-03-17","last_seen":"2025-10-24"},{"type":"issuer","type_label":"ISSUER","cik":"0000907562","name":"DYAX CORP","url":"/issuer/0000907562","role":"Officer (EVP & Chief Commercial Officer)","n_filings":1,"first_seen":"2015-08-06","last_seen":"2015-08-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001605767","retrieved_at":"2026-08-24T05:22:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}